Pillars of Health: Networking
What is Pillars of Health?
Healthcare innovation cannot be done in silos. It requires the interplay of various actors with different expertise: researchers, entrepreneurs, clinicians, healthcare administrators, government officials, and industry executives. These are the people that make up the pillars of health and represent the sectors that have played integral roles in the development and maintenance of human health. In order to truly drive meaningful healthcare innovation, its stakeholders must work together.
Pillars of Health is an interdisciplinary networking event with the mission to provide a platform for members of the health community to interact, discuss ideas, and share information in a free and open space. Hosted in partnership with the Health Innovation Hub (H2i) and the University of Toronto's Translational Research Program, it is a unique opportunity to establish signifcant connections with likeminded individuals across traditional silos. Read more about our event here!
If you are a current or aspiring member of the health community with a passion for advancing Canadian innovation in health and life sciences, please join us on October 29th, 2018 from 4PM-7PM for our fourth #pillarsofhealthTO.
3:30PM - 4:30PM: Registration. **Note: Waitlist tickets will be released by 4:30PM; non-registered ticket-holders will not be allowed to enter.
4:45PM - 5:15PM: Speakers' remarks.
5:15PM - 7:15PM: Open networking. Food and refreshments will be provided.
Allan F. Miranda As Head of Johnson & Johnson Innovation, JLABS in Canada, Allan F. Miranda is responsible for external engagement, innovation sourcing, company onboarding, portfolio management, operational excellence, educational programming and P&L. He catalyzes and supports the translation of science and technology into valuable solutions for patients and consumers across the pharmaceutical, medical device, consumer and healthtech sectors.
Allan joined the JLABS team from Janssen Canada, where he has spent the last 12 years in positions of increasing responsibility in business development, marketing and market access. His most recent role was Therapeutic Lead Immunology and Primary Care where he was responsible for market access strategy for a complex product portfolio exceeding $1 billion. Allan started his career at PARTEQ Innovations, the technology transfer arm of Queen's University at Kingston where he was responsible for technology assessment and new company start-up. He then moved to Paladin Labs, where he successfully completed numerous in-licensing transactions for specialty pharmaceutical products for the Canadian market. Allan subsequently worked in business development for two early stage biotechnology companies in Canada leading their business development and partnering initiatives prior to joining Janssen.
Allan received his Ph.D. in Neuropharmacology from Queen's University at Kingston, Ontario and his MBA from McGill University in Finance and Strategy.
Health Innovation Networking Event